Price Alert

VistaGen Therapeutics Inc... (VTGN)

NASDAQ: VTGN · Real-Time Price · USD

3.17

0.11 (3.59%)

At close: Aug 22, 2025, 3:59 PM

3.24

2.33%

After-hours: Aug 22, 2025, 05:54 PM EDT

VistaGen Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Net Income	-51.42M	-29.36M	-59.25M	-47.76M	-17.93M
Depreciation & Amortization	635K	568K	509.8K	711.1K	117.6K
Stock-Based Compensation	4.32M	2.18M	3.34M	3.48M	2.31M
Other Working Capital	-921K	271K	2.96M	-1.69B	3.48M
Other Non-Cash Items	-389K	6K	-929.14M	232K	2.53M
Deferred Income Tax	n/a	n/a	932.8M	n/a	-2.53M
Change in Working Capital	4.76M	793K	2.03M	-1.92M	3.44M
Operating Cash Flow	-42.1M	-25.81M	-49.72M	-45.26M	-12.07M
Capital Expenditures	-191K	-61K	-212K	-200.4K	-275.4K
Cash Acquisitions	n/a	n/a	-528.3K	n/a	n/a
Purchase of Investments	-24.98M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	12.03M	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-13.15M	-61K	-740.3K	-200.4K	-275.4K
Debt Repayment	n/a	-985K	-1.04M	-3K	-382K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	-945.1M	-1.39B
Other Financial Acitivies	201K	8K	n/a	951.15M	1.39B
Financial Cash Flow	3.21M	128.4M	-1.04M	10.48M	114.1M
Net Cash Flow	-52.03M	102.53M	-51.5M	-34.97M	101.75M
Free Cash Flow	-42.29M	-25.87M	-49.93M	-45.46M	-12.35M